As risks become increasingly interconnected, traditional assessment methods are struggling to keep pace. John Rogula, risk ...

Myriad Genetics (MYGN) announced a study revealing that more patients completed hereditary cancer testing when they used an online screening ...

The definition, diagnostic approaches, outlook, and understanding of causes for myocarditis have recently progressed.

Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, announced a study revealing that ...